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Abstract
Background
Paradoxical kinesis has been observed in bradykinetic people with Parkinson’s disease.
Paradoxical kinesis occurs in situations where an individual is strongly motivated or influ-
enced by relevant external cues. Our aim was to induce paradoxical kinesis in the labora-
tory. We tested whether the motivation of avoiding a mild electric shock was sufficient to
induce paradoxical kinesis in externally-triggered and self-initiated conditions in people with
Parkinson’s disease tested on medication and in age-matched controls.
Methods
Participants completed a shock avoidance behavioural paradigm in which half of the trials
could result in a mild electric shock if the participant did not move fast enough. Half of the tri-
als of each type were self-initiated and half were externally-triggered. The criterion for avoid-
ing shock was a maximummovement time, adjusted according to each participant’s
performance on previous trials using a staircase tracking procedure.
Results
On trials with threat of shock, both patients with Parkinson’s disease and controls had faster
movement times compared to no potential shock trials, in both self-initiated and externally-
triggered conditions. The magnitude of improvement of movement time from no potential
shock to potential shock trials was positively correlated with anxiety ratings.
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Conclusions
Whenmotivated to avoid mild electric shock, patients with Parkinson’s disease, similar to
healthy controls, showed significant speeding of movement execution. This was observed in
both self-initiated and externally-triggered versions of the task. Nevertheless, in the ET condi-
tion the improvement of reaction times induced by motivation to avoid shocks was greater for
the PD patients than controls, highlighting the value of external cues for movement initiation in
PD patients. Themagnitude of improvement from the no potential shock to the potential shock
trials was associated with the threat-induced anxiety. This demonstration of paradoxical kinesis
in the laboratory under both self-initiated and externally-triggered conditions has implications
for motivational and attentional enhancement of movement speed in Parkinson’s disease.
Introduction
Bradykinesia, or slowness of movement, is one of the main symptoms of Parkinson’s disease
(PD) and has a negative impact on the quality of life of patients [1]. People with PD can some-
times overcome their bradykinesia and move normally for a short time. This is known as para-
doxical kinesis (PK). Some instances of PK are dramatic, such as fleeing from a fire [2], while
others are more mundane, such as catching a ball [3]. A better understanding of PK could help
pinpoint the nature of movement deficits in PD and contribute to better therapeutic strategies.
PD patients who experience bradykinesia have problems with planning, initiating and exe-
cuting movements [4]. The most obvious manifestation of bradykinesia is a slow, shuffling gait
with reduced stride length, but all movements, including arm movements and speech, are
affected. Freezing, a temporary blocking of movement despite the intention to move, can also
occur and can affect gait, arm movements and speech. Dopamine replacement therapy can
reduce bradykinesia, but often does not alleviate it completely, especially as PD progresses.
Paradoxical kinesis was first described by Souques [5] who reported on severely bradyki-
netic patients who could sometimes move normally. One patient could climb stairs but strug-
gled to walk in other circumstances. Luria [6] found that his PD patients could only walk
across the floor when pieces of paper were placed on it ‘to stimulate each step’, but could climb
ladders. Purdon-Martin [7] showed that bradykinetic parkinsonian patients could walk at nor-
mal speed over transverse lines, placed step-length apart. PK in emergency situations has also
been reported, most notably during the L’Aquila earthquake in 2009. All 14 parkinsonian
patients interviewed after the earthquake had been able to get up during the night and flee their
homes and many helped others to escape [8].
Experimental studies on PK suggest that motivation may be an important factor. Three out
of four parkinsonian patients were able to improve on their best arm movement speed when
offered sixpence or a packet of cigarettes [9]. PD patients trained on an arm movement task
with smiley and sad faces as feedback improved their movement speed to reach the same range
as controls [10]. People with PD and healthy controls moved 7% faster in an ‘urgent’ condition
compared to an externally cued condition when asked to press a button to stop a ball rolling off
a slope [11]. In this study task difficulty was adjusted for individual participants, allowing a
PK-like increase in movement speed to be demonstrated in healthy controls. In another study,
speech duration increased by 49% in PD patients who talked about experiences of anger or
fear, which are associated with high physiological arousal [12].
External stimuli can also increase movement speed in PD patients, particularly compared to
self-initiated movements. PD patients were 54% slower than controls on a self-initiated (SI)
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button press, but both groups improved by 16% when the movement was triggered by an exter-
nal cue (ET) [11]. When asked to press a button to stop a cartoon character on a screen being
run over by a car, PD patients were 50% slower than controls in a SI condition and improved
by 4–8% in an ET condition [13]. In a task that involved reaching for a stationary ball (SI) and
a ball rolling down a ramp (ET), PD patients were 59% slower than controls in the SI condition
but matched the controls’ performance in the ET condition [14].
It should also be noted that motivational enhancements of movement speed have been
described in healthy individuals. Ballanger et al. [11] found similar enhancements of move-
ment speed in PD patients and healthy controls in a ball-catching task, where both groups
were able to move faster than their previous maximum speed in an ‘urgent’ condition. Ballan-
ger et al. [11] suggested that reports of motivational increases in movement speed in healthy
individuals in PK experiments are rare because most PK studies tend to have an upper limit on
movement speed in their tasks, which affects healthy controls, but not PD patients. Schmidt
et al. [15] found greater grip force production in healthy participants when higher monetary
incentives were offered. There have also been a number of anecdotal reports of people showing
extraordinary strength (e.g. lifting a car to rescue someone), which may be examples of motiva-
tional enhancement of movement in healthy individuals [16]. We would therefore suggest that
it is reasonable to expect an increase in movement speed in healthy controls as well as PD
patients in the current study.
In the present study we were interested in investigating the effects of motivation as well as
external cuing on movement speed in PD and healthy controls. Therefore, we developed a task
that incorporated both motivational and external cueing components. The task required partic-
ipants to react to stimuli presented on the screen by releasing a ‘home’ key and moving to press
another ‘response’ key as fast as they could. At the start of each trial there was a warning signal
indicating whether or not they could receive a mild electric shock if they did not move fast
enough. They performed two types of movements—self-initiated (SI) and externally-triggered
(ET) and received feedback at the end of each trial as to whether they had moved fast enough.
The criterion for receiving a shock was the threshold movement time that was set for each indi-
vidual on each trial using a staircase tracking procedure, based on each participant’s perfor-
mance on previous trials. Our hypotheses were first, that both people with PD and healthy
controls would move faster under the threat of a mild electric shock. Second, we expected peo-
ple with PD to perform at similar speeds to healthy controls in the externally-triggered condi-
tion, but that controls would move faster than PD patients in the self-initiated condition.
Methods
Participants
The study was approved by the Joint Ethics Committee of the Institute of Neurology and the
National Hospital for Neurology and Neurosurgery. All participants were screened for demen-
tia (see below) and none were demented and all had capacity to consent. Informed consent was
obtained from all participants in writing before starting the study. 16 PD patients and 17 con-
trols were recruited. One PD patient did not perform the task correctly and another scored less
than 25 on the MMSE. They were therefore excluded. One control did not perform the task
correctly and two others had missing data on the main task due to technical problems. Data
from 14 PD patients (10 male, 12 right-handed) and 14 (10 male, 13 right handed) healthy
age-matched controls are reported. The demographic and clinical details of the samples are
presented in Table 1. All patients had a clinical diagnosis of PD according to the UK Brain
Bank criteria [17]. The patients had mild to moderate PD according to Hoehn & Yahr rating
scale [18] (Table 1). The Mini Mental State Examination (MMSE [19]; the Beck Depression
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Inventory (BDI [20]; were respectively used to screen for dementia and depression. None of
the patients were cognitively impaired (MMSE score<26) or clinically depressed (BDI
score> 18). The National Adult Reading Test (NART) was used to obtain an estimate of pre-
morbid IQ and to match the two groups.
None of the control participants had any neurological or psychiatric illnesses, head injury,
and alcohol or drug abuse. The control and PD groups were matched in terms of age, estimates
of premorbid IQ (NART), global cognitive ability (MMSE), years of education, and degree of
right-handedness. While as a group the patients scored significantly higher on the BDI measure
of self-reported depression than the controls, none scored in the severely depressed range. Fur-
thermore, more detailed analysis showed that relative to the controls, the PD patients had
higher scores on the somatic items of the BDI which somewhat overlap with PD symptoms but
not the cognitive/affective component of depression (Table 1).
Equipment
The program was run on a Dell Optiplex GX520 (3.0 GHz) computer running MATLAB
R2010a. A custom-built button box with 2 buttons was used to record responses. The buttons
were 2.5cm in diameter and 15cm apart (measured from the centre of each button). Both
buttons were directly in front of the participant, with the ‘home’ key being nearer and the
‘response’ key further away. Shock was delivered using a Digitimer Constant Current Stimula-
tor Model D57A set to a pulse width of 2000μs and 400V. Shock ranged from 0.3 to 3.8mA
according to each participant’s threshold and was delivered in a 1s train of 50ms pulses via an
electrode with metal contacts attached to the forearm just above the wrist with a Velcro strap.
Shock Avoidance Behavioural Paradigm
The shock level was calibrated for each individual, starting at 0 and moving up in steps of
0.2mA until the participant reported the shock as being unpleasant but not painful. After this
shock calibration procedure, participants were provided with verbal and on-screen instructions
about the shock avoidance behavioural paradigm. Fig 1 shows the sequence of events on the
Table 1. Demographic data and scores on tests of cognition, executive function andmood scales for
controls and patients with Parkinson’s disease (PD). The data are means (±SEM).
Control PD p
N 14 14 -
Gender 10 male 10 male 1.00
Age 68 (1.69) 65.00 (1.95) .26
MDS-UPDRS (Motor part) - 35.31 (3.37) -
Medication (L-DOPA equivalent) - 761.94(150.27) -
Hoehn and Yahr stage - 2.06(0.07) -
Education (years) 15.64 (0.88) 14.86 (0.60) .47
Handedness (EHI) 72.29 (10.54) 58.93 (14.26) .46
BDI (total) 5.04 (1.16) 11.82 (1.96) .006
Non-somatic (questions 1–14) 3.11 (1.09) 6.29 (1.46) .09
Somatic (questions 15–21) 1.93 (1.07) 5.50 (0.60) < .001
MMSE 29.29 (0.27) 29.43 (0.23) .67
NART IQ 122.29 (1.64) 121.29 (1.33) .64
MDS UPDRS = Movement Disorder’s Society Uniﬁed Parkinson’s Disease rating Scale; EHI = Edinburgh
Handedness Inventory; BDI = Beck Depression Inventory; MMSE = Mini Mental State Examination; NART
IQ = National Adult Reading Test Intelligence Quotient.
doi:10.1371/journal.pone.0135149.t001
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Fig 1. The Shock Avoidance Behavioural paradigm with self-initiated (A) and externally-triggered (B) conditions.
doi:10.1371/journal.pone.0135149.g001
Paradoxical Kinesis in Parkinson's Disease
PLOS ONE | DOI:10.1371/journal.pone.0135149 August 18, 2015 5 / 14
screen during the different types of trials of the task. When a white fixation cross appeared in
the middle of the black screen, participants were required to fixate on the white cross and press
down and hold the near ‘home’ key on the button box. After a variable delay of 2–6s, a red or
blue border appeared around the edge of the screen. A red border indicated a potential shock
(PS) trial and warned the participant that there could be a shock delivered on that trial if they
did not move fast enough (at individually set criterion for movement speed, defined below)
from the near to the far button. A blue border signalled a no potential shock (NPS) trial and
that there would be no shock on that trial. On self-initiated (SI) trials (Fig 1A), participants
were then asked to wait for a variable time of 2–7s before moving as fast as they could from the
‘home’ to the ‘response’ button. In externally-triggered (ET) trials (Fig 1B), participants were
instructed to release the ‘home’ key and press the response button as fast as possible following
the presentation of the green square (external signal) on the screen. After each trial, the partici-
pant received feedback, lasting for 600 ms, via a cartoon face—a smiley or a sad face on PS trials
or a neutral face on NPS trials—as to whether they had moved fast enough. A shock was deliv-
ered immediately after the response button press simultaneously with the ‘sad’ face if partici-
pants failed to move fast enough on a PS trial.
There were eight blocks of 40 trials each. Half of the blocks were SI and half were ET. In
each block, all trials were either SI or ET. The first block was SI and the block types then alter-
nated, with the delay between the border change and appearance of the green square to trigger
movement in each ET trial being yoked to the delay between the border change and start of the
participant’s movement in the previous SI block. Within each block, 20 PS and 20 NPS trials
were delivered in a pseudo-random order, so that there could be no more than 3 consecutive
trials of one type. The criterion for shock delivery was a threshold movement time, which was
set for each trial for each participant using a staircase tracking procedure, with an initial value
of 300ms, which reduced by 20ms every time shock was successfully avoided and increased by
50ms every time a participant received a shock.
Movement times (MTs) were measured in both the SI and ET conditions and reaction times
(RTs) were measured in the ET condition. MTs were measured as the time between the partici-
pant releasing the home button and pressing the response button. In the ET condition, RTs
were measured as the time between presentation of the green square ‘go’ stimulus and release
of the home button by the participant. In the SI blocks, the waiting time (WT) was calculated
as the difference between the time of presentation of the warning stimulus and the time of
release of the home key by the participant. The difference in MT between NPS and PS trials
(MT improvement) was used for correlational analysis.
Procedure
All PD patients were tested ON medication. The Movement Disorders Society-Unified Parkin-
son’s Disease Rating Scale (MDS-UPDRS) rating scale [21] was used to assess the severity of
the motor symptoms at the time of the experiment by an experienced neurologist (AA). All
participants rated their anxiety on a 0 (not at all anxious)-10 (very anxious) scale before start-
ing the shock avoidance paradigm and immediately after it ended. The Edinburgh Handedness
Inventory [22] was used to quantify the degree of right-handedness. The screening measures
(MMSE, BDI, NART) were completed after the shock avoidance paradigm.
Analysis
All statistical analyses were completed with SPSS(v19). Demographic data were compared
between the control and PD groups using independent groups’ t-tests for interval data and χ2
for categorical data. Anxiety before and after the experiment was analysed using a repeated
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measures ANOVA with Time of Assessment (Before vs. After) as within-subject factor and
Group (PD vs. controls) as between-subject factor.
Parametric tests were used because the raw MT and RT data were normally distributed and
had homogeneous variances. Data, which represented counts (i.e. number of shocks received)
were analysed using the χ2 test.
MTs and RTs were summarised into mean values for each individual for each combination
of Condition (Self-initiated (SI) versus Externally-triggered (ET)) and Trial Type (Potential
Shock (PS) versus No Potential Shock (NPS)). MT was the main outcome measure and was
analysed using repeated measures ANOVA with Condition (SI or ET) and Trial Type (PS or
NPS) as the within-subjects factors and Group (control or PD) as the between-groups factor.
RT for ET blocks was analysed using a repeated measures ANOVA with Trial Type (PS or
NPS) as the within-subject factor and Group (control or PD) as the between-groups factor.
Correlations between each participant’s average MT improvement between NPS and PS tri-
als and their anxiety ratings were calculated using Pearson’s correlation coefficient.
Results
The control and PD groups were well matched in terms of demographic variables, and esti-
mates of premorbid IQ. There was no significant differences between the groups on any mea-
sure except for BDI, where the PD group scored higher (t(26) = -2.99, p = .006, r = .491).
However, when BDI scores were divided into non-somatic (questions 1–14) and somatic
(questions 15–21) items [23], there was no difference between the groups on non-somatic
items (t(26) = -1.75, p = .09, r = .313), and the PD group scored significantly higher on somatic
items (t(18.7) = -5.39, p< .001, r = .715). See Table 1 for details.
Anxiety was rated by the participants on a scale of 0 (low) to 10 (high) before and after the
shock avoidance paradigm. Before the paradigm, controls reported a mean anxiety of 1.43
(SD = 1.83) and PD patients reported a mean anxiety of 2.07 (SD = 2.24). After the shock avoid-
ance paradigm, controls reported a mean anxiety of 1.07 (SD = 1.87) and PD patients reported a
mean anxiety of 1.71 (SD = 1.83). An ANOVA on anxiety ratings before and after the shock
avoidance paradigm for controls and PD patients showed no effect of Group (F(1,26) = 1.09, p =
.304, η2 = .304) or time of assessment (before vs. after shock avoidance) (F(1,26) = 0.78, p = .384,
η2 = .029) and no significant interaction (F(1,26)<1, p = 1.00, η2 = .000).
Impact of threat of shock on speed of movement initiation and execution
Both healthy controls and PD patients demonstrated increased movement speed, moving faster
when threatened with shock in both the SI and ET conditions (see Fig 2). The
Group × Condition × Trial Type ANOVA onMT produced a significant main effect of Trial
Type (F(1, 26) = 12.11, p = .002, η2 = .331), with MTs on PS trials being significantly faster
than on NPS trials. This improvement of MTs with threat of shock was observed across both
groups and movement speed increased by 8–9% for PD patients and 13–15% for the controls.
There were no other significant main or interaction effects.
The analysis of RTs was done for the ET trials, as there is no true RT measure in SI trials.
The mean RTs for the PS and NPS trials of the ET condition for the controls and PD patients
are shown in Fig 3. A two-way repeated measures ANOVA on Trial Type (Shock versus No
Shock) and Group (Control versus PD) showed a significant effect of Trial Type (F(1,26) =
40.49, p< .002, η2 = .609), no significant effect of Group (F(1,26) = .39, p = .540, η2 = .015),
but a significant Group × Trial Type interaction (F(1,26) = 6.42, p = .018, η2 = .198). Simple
main effects tests on the effect of Trial Type for each Group showed that both controls
(F(1,13) = 10.01, p = .007, η2 = .435) and PD patients (F(1,13) = 31.23, p< .0001, η2 = .706)
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had significantly faster RTs in the ET condition on PS trials compared to NPS trials. Thus the
threat of shock significantly reduced RT for PD patients and controls. However, this improvement
Fig 2. Movement time (ms) for controls and patients with Parkinson’s disease (PD) in self-initiated (SI) and externally-triggered (ET) conditions for
the potential shock (PS) and no potential shock (NPS) trials.
doi:10.1371/journal.pone.0135149.g002
Fig 3. Reaction time (ms) for controls and patients with Parkinson’s disease (PD) in the externally-triggered condition in potential shock (PS) and
no potential shock (NPS) trials.
doi:10.1371/journal.pone.0135149.g003
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in RTs with threat of shock was significantly greater in PD patients (mean = 70.31, SD = 47.08)
than in healthy participants (mean = 30.27, SD = 35.78) (t(26) = 2.53, p = .018, r = .403) (Fig 3).
There was no significant difference in the WT for the SI blocks between PD (mean
WT = 1907.93, SD = 1353.23) and healthy controls (mean WT = 1933.14, SD = 1176.81)
(p = .946). As expected, across both groups, the waiting time was shorter in the PS (mean
WT = 1851.74, SD = 1116.04) compared to NPS trials (mean WT = 1989.14, SD = 1204.81)
(F(1,13) = 18.65, p< .0001, η2 = .400). The Group × Trial Type interaction for WT was not sig-
nificant F(1,26) = 0.73, p = 401, η2 = .025).
Although the PD patients chose a slightly higher average shock level (mean = 1.59mA,
SD = 0.52) than the control participants (mean = 1.47mA, SD = 1.18), there was no significant
difference between the groups (t(17.86) = -0.343, p = .735, r = 0.065). Application of the stair-
case tracking procedure adjusted the MT shock criterion individually for each participant in
the course of the experiment, to ensure that all participants received approximately the same
number of shocks. The mean MT criterion for delivery of shock was 175.32ms (SD = 74.11) for
control participants and 198.27ms (SD = 67.11) for PD patients. These were not significantly
different (t(26) = -0.859, p = .398, r = .160). Controls and PD patients received similar numbers
of shocks during the experiment (χ2 = 3.56, p = .47, r = .356), with both groups receiving
shocks on 20% of PS trials.
The magnitude of improvement of MTs from NPS to PS trials positively correlated with
anxiety ratings after the shock avoidance paradigm (r(28) = .47, p = .01) as well as with the
shock criterion (r(28) = .487, p = .009). The raw data of the experiment can be found in the
Supporting Information (S1 File).
Discussion
PD patients had a faster MT in the potential shock (PS) than the no potential shock (NPS) con-
dition, demonstrating paradoxical kinesis (PK) in an experimental setting. Healthy controls
also showed an increase in movement speed from the NPS to PS condition. There was no dif-
ference in the increase in movement speed between SI and ET conditions. In addition, both PD
patients and healthy controls had faster RTs in the ET condition when threatened with mild
electric shock; this improvement of RTs was greater for PD patients than controls.
Bradykinesia in PD has been described as “insufficient motor energy” and it has been dem-
onstrated that PD patients could move faster but ordinarily chose not to do so, because of the
energetic cost entailed by moving at normal speed [10]. Our results confirm that when pro-
vided with appropriate motivational contexts, in the form of shock avoidance, patients with
PD can speed up their movements.
In the current study, both PD patients and controls improved their MT when faced with the
threat of mild electric shock. Across both the SI and ET conditions, the shock-induced MT
improvement for the controls (13–15%) was slightly greater than the improvement in PD
patients (8–9%), although this difference was not significant. A number of other studies have
addressed the effects of motivation on movement. Two general forms of motivation have been
studied: the motivation to earn a reward and the motivation to avoid a punishment (as in our
study). The majority of previous studies have examined the motivation to earn a reward. Hall
[9] reported increased movement speed in 3 out of 4 parkinsonian patients by offering sixpence
or a packet of cigarettes and Mazzoni et al. [10] trained PD patients to perform an arm move-
ment as fast as controls by reinforcing fast or slow movements appropriately with smiley or sad
cartoon faces. Kojovic et al. [24] found faster movement initiation in medicated and unmedi-
cated PD patients in a simple reaction time task in anticipation of monetary reward for faster
performance. Moustafa et al. [25] found that medicated PD patients were better at speeding up
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response times to earn a reward, while unmedicated PD patients were better at slowing their
responses to earn a reward in a task where participants had to choose between immediate or
delayed responses to maximise rewards. Only Shiner et al. [26] have studied the motivation to
earn a reward and the motivation to avoid a punishment in the same paradigm in PD patients
tested off medication. Participants were asked to move as fast as possible to earn money or
avoid a shock in a self-initiated task. They found that PD patients improved more on shock tri-
als than on monetary incentive trials compared to controls. This suggests that the impact of the
two forms of motivation is not behaviourally identical, although there are common features.
Our findings that PD patients (and controls) could speed up their movements further to avoid
punishment, despite already having been asked ‘to move as fast as they can’, are consistent with
previous studies. However, the results of Shiner et al. [26] suggest a difference between these
two kinds of motivational influence, monetary incentive versus shock avoidance, on movement
speed, which requires further examination in future studies.
The finding of improved movement speed in healthy controls as well as PD patients is con-
sistent with Ballanger et al. [11], who asked participants to press a button to stop a ball rolling
off a slope. Mir et al, [27], Kojovic et al. [24] and Shiner et al. [26] also found that controls
could improve on their maximum movement speeds when motivated by earning a reward or
avoiding punishment. In a grip force production task, healthy controls were able to increase
their grip force with the prospect of higher monetary rewards [15]. This suggests that motiva-
tional modulation of movement speed and force is a feature of normal motor function and
present in healthy controls as well as preserved to an extent in PD patients.
There was also a reduction of RTs in the PS condition of the ET blocks for both PD patients
and healthy controls. This speeding up of RTs was however greater in magnitude for PD
patients than the healthy controls, possibly due to a ‘floor effect’ for the controls It is possible
that altered time estimation contributes to an extent to the observed improvement of RTs with
threat of shock. However, this proposal is not consistent with previous studies on time estima-
tion under stress, which found that stress or anxiety lengthen time estimation [28, 29]. Never-
theless, threatening events are considered to speed up the rate of an “internal clock”, such that
when prompted to produce a response under threatening circumstances individuals make
responses faster than they might otherwise and perceive more time as having elapsed than
actually has [30]. Enhanced attention is another potential mechanism for the observed speed-
ing of RTs with threat of shock. Paying attention to making larger movements has been shown
to improve movement speed in PD [31], so it is possible that participants focusing their atten-
tion on producing faster MTs in the PS condition in the current study also improved RTs. The
greater magnitude of improvement of RT with motivation to avoid shock in the ET condition
for the PD patients, but the larger improvement of MTs across SI and ET conditions for the
healthy controls, is consistent with previous findings that relative to controls, PD patients are
more impaired on SI than ET movements [32].
Operant conditioning does not explain the faster MTs and RTs in the PS condition, as the
MT criterion for shock delivery was altered in every trial using a staircase tracking procedure,
so conditioning to a consistent criterion would not have taken place. Even in a PS trial, there
was only a 20% chance of receiving a shock, suggesting that any conditioning that might have
taken place would have been more likely to be in the direction of non-occurrence of shock and
cannot provide an alternative explanation for faster MTs in this condition. The 80% likelihood
of non-occurrence of shock is the same probability that is employed for conditioning in proba-
bilistic learning experiments [33], so was the more likely contingency to be learned here.
The magnitude of MT improvement from the no potential shock to the potential shock tri-
als was positively correlated with anxiety scores after the shock avoidance paradigm. It is possi-
ble to maintain and even improve task performance when anxiety is increased by the threat of
Paradoxical Kinesis in Parkinson's Disease
PLOS ONE | DOI:10.1371/journal.pone.0135149 August 18, 2015 10 / 14
shock, as shown by Robinson et al. [34], who found sustained performance and enhanced neg-
ative bias when participants completing an emotional Stroop task were threatened with shock.
Motivational modulation of movement speed, as in the current study, suggests that the lim-
bic system can influence the motor system. Such motivational modulation of movement could
be mediated via the ventral tegmental area (VTA) and the nucleus accumbens (NA) which
form a limbic-motor interface with the vental pallidum (VP), as the medial sections of these
structures (NAshell, VPm, VTA) receive limbic input; whereas the lateral sections (NAcore,
VPl, substantia nigra) are connected to the motor system. There are also afferents from the
VTA to the limbic system and efferents from the limbic system to the cingulate cortex, via the
thalamus [35]. The VTA together with the substantia nigra, is involved in the relationship
between stimuli and movement [36] and the cingulate cortex has been activated in studies
demonstrating PK in PD patients and similar motivational enhancement of movement in con-
trols [37–39]. In fMRI studies of the effects of monetary incentive on grip force production [15,
40], activation in the VP and ventral striatum was correlated with the behavioural effects of
incentives on grip force.
Limitations and future directions
We expected to find faster MTs in the ET version of the task, compared to the SI version, par-
ticularly for the PD patients, but the MTs were similar in both conditions. This may be a genu-
ine finding, but it may also be a consequence of the warning signal indicating the start of both
the SI and ET trials effectively reducing the extent of self-initiation in the SI trials. This possi-
bility needs to be checked in future studies with an SI task without a warning signal before each
trial, although there are considerable practical difficulties in designing such a task.
There was no difference in MT between controls and PD patients. This may have been due
to the PD patients being tested while on dopaminergic medication which effectively controlled
their motor symptoms. It has been proposed that tonic levels of dopamine have an energizing
effect and control response vigor [41]. If response vigor is modulated by striatal dopamine,
then it would be of interest to determine whether the speeding of MT with threat of shock is
different when patients are tested off medication. Future investigation of motivational modula-
tion of movement speed in subgroups of PD patients with motivational deficits due to apathy
or depression would also be of interest.
A novel feature of our paradigm was testing for motivational modulation of movement
speed in both ET and SI conditions. There is substantial evidence that bradykinetic PD patients
have fewer problems when movements are ET than SI and move faster in ET tasks (e.g. [13,
32]. Observations of PK in PD often include situations with external stimuli such as a fire or
transverse lines [7] or catching a ball [3]. However, we found no difference in the threat of
shock-induced improvement of MT, between ET and SI conditions for either PD patients or
controls, suggesting that motivational modulation of movement speed occurs for both types of
movement. It may be necessary for a motivational element to be present, such as the wish of
avoiding shock, for motivational increases in movement speed to be present under SI condi-
tions. Another possible explanation for the presence of motivational increases in movement
speed in our SI task might be that the warning signal (the screen border change that signalled
whether a trial was PS or NPS). A similar signal was present in the Shiner et al. [26] study—
participants were instructed to wait for the disappearance of a cue—and is difficult to avoid, as
participants need to be given a starting signal of some kind even in SI conditions. A warning
signal significantly speeded up RT and MT in a button press task when given at intervals from
200–3200ms before the task start signal [42], so could have reduced the difference between SI
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and ET tasks in this paradigm. The potential effect of the warning signal should be tested in a
version of this task without a warning signal preceding each trial.
Conclusions
This study demonstrated PK in PD patients tested on medication and a similar motivational
enhancement of movement speed in age-matched controls in a task where faster movements
were motivated by the threat of mild electric shock. PK was demonstrated in both the ET and
SI versions of the task and this may be the first experimental demonstration of PK in PD in a SI
task. Such motivational modulation of movement speed suggests the possibility of limbic sys-
tem influencing and interacting with the motor system. Further work is needed to extend the
demonstration of PK in an SI task to an SI task without a warning signal and to test whether
PK can be elicited in this task in PD patients off medication. Future investigation of the neural
substrates of the observed motivational modulation of movement speed in this shock avoid-
ance paradigm in healthy controls and patients with PD will clarify if the threat of shock
induced improvement of MT is similarly mediated in the two groups. Such motivational mod-
ulation of movement speed in PD may have therapeutic applications to teach patients to over-
come bradykinesia.
Supporting Information
S1 File. This file contains the raw data for every participant separately. RT = Reaction Time,
MT =Movement Time, Exact time of: trial start, home key press and release, warning signal
appearance, target key press, feedback and Inter Trial Interval (ITI).
(XLSX)
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